Predictive Oncology Inc (POAI)

[crudeoil24]

SEC filing 424B3 > 16,671,747 Shares of Common Stock



This prospectus supplement (“Supplement”) modifies, supersedes and supplements certain information contained in, and should be read in conjunction with, that certain prospectus (the “Prospectus”) filed with the Securities and Exchange Commission (the “SEC”) by Predictive Oncology Inc. (the “Company”), dated March 23, 2021, related to the resale from time to time by the selling stockholders named therein of 16,671,747 shares of the Company’s common stock, par value $0.01 per share (“Common Stock”), including (i) shares of Common Stock issuable upon exercise of outstanding warrants at an original exercise price of $2.00 per share expiring on August 16, 2026 and (ii) shares of Common Stock issuable upon exercise of outstanding warrants at an original exercise price of $2.00 per share expiring on August 23, 2026. Together, such warrants to purchase shares of Common Stock at the exercise price of $2.00 per share are referred to as the “Existing Warrants,” and some of the Existing Warrants have been amended as described below under “Amendments to Existing Warrants.”



The Common Stock is listed on the Nasdaq Capital Market under the symbol “POAI.” On May 18, 2022, the last reported sale price of the Common Stock on the Nasdaq Capital Market was $0.336 per share.